Table 1.
Demographic and Human Immunodeficiency Virus Type 1 (HIV-1)–Associated Characteristics of Study Participants, by HIV-1 Status and Subtype
| Characteristic | HIV-1 Negative (n = 22) | HIV-1 Positive, by Subtype (n = 156) |
||
|---|---|---|---|---|
| A (n = 24) | AD (n = 35) | D (n = 97) | ||
| Sex, participants, no. (%) | ||||
| Female | 13 (59) | 16 (67) | 19 (54) | 65 (67) |
| Male | 9 (41) | 8 (33) | 16 (46) | 32 (33) |
| Age, y, mean ± SD | 31 ± 8 | 26 ± 8 | 27 ± 7 | 28 ± 7 |
| Time from seroconversion, d | NA | 564 (327–1356) | 581 (322–1270) | 588 (209–2054) |
| CD4 T-cell absolute count, cells/μLa | 731 (708–938) | 694 (245–1281) | 509 (270–1492) | 495 (98–1484) |
| HIV-1 load, copies/mL | NA | 25 692 (2148–427 096) | 28 555 (839–761 664) | 41 713 (262–1 330 850) |
| Study end point reached, participants, no. | ||||
| AIDS | NA | 7 | 14 | 48 |
| Death | NA | 3 | 12 | 25 |
Data are median value (range), unless otherwise indicated.
Abbreviations: NA, not applicable; SD, standard deviation.
a No. of individuals used for CD4 T-cell absolute counts: HIV-1 subtype A, 12; subtype AD (recombinant/dual infection), 16; and subtype D, 46.